EN HU

Mohamed Mahdi

Mohamed Mahdi

Publication list

Uploaded publications:
28
Publications in DEA:
28
OA:
22
Date range:
2010-2025
2025
1.
Fekete, M., Lehoczki, A., Szappanos, Á., Tóth, A., Mahdi, M., Sótonyi, P., Benyó, Z., Yabluchanskiy, A., Tarantini, S., Ungvári, Z.: Cerebromicrovascular mechanisms contributing to long COVID: implications for neurocognitive health.
GeroScience. [Epub ahead of print], 2025.
Journal metrics:
Q1 Aging (2024)
Q1 Cardiology and Cardiovascular Medicine (2024)
D1 Complementary and Alternative Medicine (2024)
Q1 Geriatrics and Gerontology (2024)
D1 Veterinary (miscellaneous) (2024)
2.
Mahdi, M., Srivastava, V.: Editorial: Cellular and host immune responses in the context of dual viral infection.
Front. Immunol. 16, 1-2, (article identifier: 1641084), 2025.
3.
Mótyán, J. A., Nagy, T., Veres, Á., Golda, M., Mahdi, M., Tőzsér, J.: Identification of SARS-CoV-2 Main Protease Cleavage Sites in Bovine β-Casein.
Int. J. Mol. Sci. 26 (12), 1-11, (article identifier: 5829), 2025.
Journal metrics:
Q2 Catalysis (2024)
Q1 Computer Science Applications (2024)
Q1 Inorganic Chemistry (2024)
Q1 Medicine (miscellaneous) (2024)
Q2 Molecular Biology (2024)
D1 Organic Chemistry (2024)
Q1 Physical and Theoretical Chemistry (2024)
D1 Spectroscopy (2024)
4.
Mahdi, M., Kiarie, I. W., Mótyán, J. A., Hoffka, G., Al-Muffti, A. S., Tóth, A., Tőzsér, J.: Receptor Binding for the Entry Mechanisms of SARS-CoV-2: Insights from the Original Strain and Emerging Variants.
Viruses-Basel. 17 (5), 1-25, (article identifier: 691), 2025.
Journal metrics:
Q1 Infectious Diseases (2024)
Q1 Virology (2024)
5.
Szojka, Z., Kunkli, B., Kiarie, I. W., Linkner, T. R., Al-Muffti, A. S., Ahmad, H., Benkő, S., Jansson, M., Tőzsér, J., Mahdi, M.: Transcriptomic Analysis Reveals Key Pathways Influenced by HIV-2 Vpx.
Int. J. Mol. Sci. 26 (8), 1-21, (article identifier: 3460), 2025.
Journal metrics:
Q2 Catalysis (2024)
Q1 Computer Science Applications (2024)
Q1 Inorganic Chemistry (2024)
Q1 Medicine (miscellaneous) (2024)
Q2 Molecular Biology (2024)
D1 Organic Chemistry (2024)
Q1 Physical and Theoretical Chemistry (2024)
D1 Spectroscopy (2024)
2024
6.
Linkner, T. R., Ambrus, V. A., Kunkli, B., Szojka, Z., Kalló, G., Csősz, É., Kumar, A., Emri, M., Tőzsér, J., Mahdi, M.: Comparative Analysis of Differential Cellular Transcriptome and Proteome Regulation by HIV-1 and HIV-2 Pseudovirions in the Early Phase of Infection.
Int. J. Mol. Sci. 25 (1), 1-26, (article identifier: 380), 2024.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
7.
Tóth, E., Fagyas, M., Nagy, B. J., Mányiné Siket, I., Szőke, B., Mártha, L., Mahdi, M., Erdősi, G., Pólik, Z., Kappelmayer, J., Papp, Z., Borbély, A., Szabó, T., Balla, J., Balla, G., Bácsi, A., Szekanecz, Z., Bai, P., Tóth, A.: Distinct subsets of anti-pulmonary autoantibodies correlate with disease severity and survival in severe COVID-19 patients.
GeroScience. 46 (2), 1561-1574, 2024.
Journal metrics:
Q1 Aging
Q1 Cardiology and Cardiovascular Medicine
D1 Complementary and Alternative Medicine
Q1 Geriatrics and Gerontology
D1 Veterinary (miscellaneous)
8.
Kiarie, I. W., Hoffka, G., Laporte, M., Leyssen, P., Neyts, J., Tőzsér, J., Mahdi, M.: Efficacy of Integrase Strand Transfer Inhibitors and the Capsid Inhibitor Lenacapavir against HIV-2, and Exploring the Effect of Raltegravir on the Activity of SARS-CoV-2.
Viruses-Basel. 16 (10), 1-15, (article identifier: 1607), 2024.
Journal metrics:
Q1 Infectious Diseases
Q1 Virology
9.
Papp, H., Tóth, E., Bóvári-Biri, J., Bánfai, K., Juhász, P., Mahdi, M., Russo, L. C., Bajusz, D., Sipos, A., Petri, L., Szalai, T. V., Kemény, Á., Madai, M., Kuczmog, A., Batta, G., Mózner, O., Vaskó, D., Hirsch, E., Bohus, P., Méhes, G., Tőzsér, J., Curtin, N., Helyes, Z., Tóth, A., Hoch, N. C., Jakab, F., Keserű, G. M., Pongrácz, J., Bai, P.: The PARP inhibitor rucaparib blocks SARS-CoV-2 virus binding to cells and the immune reaction in models of COVID-19.
Br. J. Pharmacol. 181 (23), 4782-4803, 2024.
Journal metrics:
D1 Pharmacology
2023
10.
Miltner, N., Kalló, G., Csősz, É., Miczi, M., Nagy, T., Mahdi, M., Mótyán, J. A., Tőzsér, J.: Identification of SARS-CoV-2 Main Protease (Mpro) Cleavage Sites Using Two-Dimensional Electrophoresis and In Silico Cleavage Site Prediction.
Int. J. Mol. Sci. 24 (4), 1-19, (article identifier: 3236), 2023.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
2022
11.
Bakos, I., Mahdi, M., Kardos, L., Nagy, A., Várkonyi, I.: Clinical Spectrum and CSF Findings in Patients with West-Nile Virus Infection, a Retrospective Cohort Review.
Diagnostics. 12 (4), 1-9, (article identifier: 805), 2022.
Journal metrics:
Q2 Clinical Biochemistry
12.
Miltner, N., Linkner, T. R., Ambrus, V. A., Al-Muffti, A. S., Ahmad, H., Mótyán, J. A., Benkő, S., Tőzsér, J., Mahdi, M.: Early suppression of antiviral host response and protocadherins by SARS-CoV-2 Spike protein in THP-1-derived macrophage-like cells.
Front. Immunol. 13, 999233, (article identifier: 999233), 2022.
Journal metrics:
Q1 Immunology
Q1 Immunology and Allergy
13.
Mótyán, J. A., Mahdi, M., Hoffka, G., Tőzsér, J.: Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: lessons Learned from HIV-1 Protease.
Int. J. Mol. Sci. 23 (7), 1-20, (article identifier: 3507), 2022.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
14.
Mahdi, M., Hermán, L., Réthelyi, J., Bálint, B. L.: Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19.
Int. J. Mol. Sci. 23 (7), 1-21, (article identifier: 3812), 2022.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
2021
15.
Linkner, T. R., Ambrus, V. A., Kunkli, B., Szojka, Z., Kalló, G., Csősz, É., Kumar, A., Emri, M., Tőzsér, J., Mahdi, M.: Cellular Proteo-Transcriptomic Changes in the Immediate Early-Phase of Lentiviral Transduction.
Microorganisms. 9 (11), 1-21, (article identifier: 2207), 2021.
Journal metrics:
Q2 Microbiology
Q2 Microbiology (medical)
Q3 Virology
2020
16.
Mahdi, M., Mótyán, J. A., Szojka, Z., Golda, M., Miczi, M., Tőzsér, J.: Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2·s main protease.
Virol. J. 17 (1), 1-8, (article identifier: 190), 2020.
Journal metrics:
Q2 Infectious Diseases
Q2 Virology
17.
Golda, M., Mótyán, J. A., Mahdi, M., Tőzsér, J.: Functional Study of the Retrotransposon-Derived Human PEG10 Protease.
Int. J. Mol. Sci. 21 (7), 1-22, (article identifier: 2424), 2020.
Journal metrics:
Q2 Catalysis
D1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
D1 Physical and Theoretical Chemistry
D1 Spectroscopy
18.
Golda, M., Mótyán, J. A., Mahdi, M., Tőzsér, J.: Study of the Retrotransposon-Derived Human PEG10 Protease.
Proceedings. 50 (1), 110, 2020.
19.
Szojka, Z., Mótyán, J. A., Miczi, M., Mahdi, M., Tőzsér, J.: Y44A Mutation in the Acidic Domain of HIV-2 Tat Impairs Viral Reverse Transcription and LTR-Transactivation.
Int. J. Mol. Sci. 21 (16), 1-17, (article identifier: 5907), 2020.
Journal metrics:
Q2 Catalysis
D1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
D1 Physical and Theoretical Chemistry
D1 Spectroscopy
2019
20.
Csősz, É., Tóth, F., Mahdi, M., Tsaprailis, G., Emri, M., Tőzsér, J.: Analysis of networks of host proteins in the early time points following HIV transduction.
BMC Bioinformatics. 20, 1-18, (article identifier: 398), 2019.
Journal metrics:
D1 Applied Mathematics
Q1 Biochemistry
D1 Computer Science Applications
Q2 Molecular Biology
Q2 Structural Biology
2018
21.
Mahdi, M., Szojka, Z., Mótyán, J. A., Tőzsér, J.: Inhibitory effects of HIV-2 Vpx on replication of HIV-1.
J. Virol. 92 (14), 1-46, (article identifier: 00554), 2018.
Journal metrics:
Q1 Immunology
D1 Insect Science
Q1 Microbiology
Q1 Virology
2015
22.
Mahdi, M., Szojka, Z., Mótyán, J. A., Tőzsér, J.: Inhibition Profiling of Retroviral Protease Inhibitors Using an HIV-2 Modular System.
Viruses. 7 (12), 6152-6162, 2015.
Journal metrics:
Q1 Infectious Diseases
Q2 Virology
2014
23.
Mahdi, M., Matúz, K., Tóth, F., Tőzsér, J.: A Modular System to Evaluate the Efficacy of Protease Inhibitors against HIV-2.
PLoS One. 9 (11), 1-13, 2014.
Journal metrics:
D1 Agricultural and Biological Sciences (miscellaneous)
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1 Medicine (miscellaneous)
2010
24.
Erdős, M., Lajszné Tóth, B., Mahdi, M., Veres, I., Kiss, M., Remenyik, É., Maródi, L.: Association of Nijmegen Breakage Syndrome with Primary Cutaneous Tuberculosis.
Clin. Microbiol. Infect. 16, s1, 2010.
25.
Constantin, T., Rákóczi, É., Ponyi, A., Ambrus, C., Kádár, K., Vastagh, I., Dajnoki, A., Lajszné Tóth, B., Bokrétás, G., Müller, V., Katona, M., Csíkós, M., Fiedler, O., Széchey, R., Varga, E., Rudas, G., Kertész, A. B., Molnár, S., Kárpáti, S., Nagy, V., Magyar, P., Mahdi, M., Németh, K., Bereczki, D., Garami, M., Erdős, M., Maródi, L., Fekete, G.: Fabry-betegség: diagnosztikai útmutató.
Orv. Hetil. 151 (7), 243-249, 2010.
Journal metrics:
Q3 Medicine (miscellaneous)
DEENK University of Debrecen
© 2012 University of Debrecen